Where others see complexity, we see clarity. Where others see rare, we see responsibility.

Our Founding
Neela Therapeutics was established in 2025 as a spin-out from Alcyone Therapeutics following Biogen’s acquisition of Alcyone. Neela is purpose-built to advance precision therapies focused on pediatric diseases.

Science with purpose. Medicine with heart.

About Us
Derived from the Sanskrit word for “blue,” Neela symbolizes healing, trust, and limitless possibility. We are building a new generation of precision pediatric therapies designed to bring real hope to children with rare and serious diseases.